Paper Details

  1. Home
  2. Paper Details

Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?

Author: OmataM, ShiratoriY

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Hepatitis C (HCV) infection can progress slowly from chronic hepatitis to liver scarring (cirrhosis), leading to liver failure or cancer. Interferon (IFN) treatment can reduce the risk of liver cancer, but only a small percentage of patients achieve a long-term response. Factors that may predict a good response to IFN include age, gender, duration of infection, alcohol use, liver disease severity, amount of virus in the blood, type of HCV, and the specific interferon treatment regimen. Monitoring virus levels during and after treatment is important to determine if the treatment is effective and to make decisions about changing or stopping treatment. While IFN treatment significantly reduces the risk of liver cancer, it is possible to develop liver cancer several years after treatment.
Paper Details　
Original Abstract of the Article :
Antiviral therapy for hepatitis C virus (HCV) infection should be based on the natural history of HCV infection; there is a sequential, but slow, progression from chronic hepatitis to cirrhosis, leading to death from either liver failure or hepatocellular carcinoma (HCC). The risk of HCC development...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1440-1746.2000.02116.x

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Hepatitis C Treatment: A Guide to Interferon Therapy

Hepatitis C virus (HCV) infection is a significant global health concern, leading to chronic liver disease and potentially life-threatening complications. This study explores the use of interferon therapy for chronic hepatitis C, examining factors that influence treatment efficacy and strategies for optimizing treatment regimens.

The authors discuss various factors that predict response to interferon therapy, including host characteristics, viral factors, and treatment-related factors. They emphasize the importance of monitoring HCV RNA levels during therapy and adjusting treatment regimens accordingly. It’s like navigating a desert – understanding the terrain and adapting to changing conditions is crucial for success.

Finding the Right Path: Optimizing Interferon Therapy for Hepatitis C

The study’s findings highlight the need for personalized treatment plans for hepatitis C, considering individual patient characteristics and viral factors. It’s like choosing the right path through the desert – each journey is unique and requires careful planning and adaptation. By tailoring treatment strategies based on these factors, we can improve the effectiveness of interferon therapy and enhance patient outcomes.

The Desert of Hepatitis C: A Quest for a Cure

This research provides valuable insights into the complexities of hepatitis C treatment, underscoring the importance of careful monitoring and individualized care. It’s like navigating a vast desert – understanding the terrain and seeking the right resources are crucial for finding a path to recovery. By continuing to explore and refine treatment strategies, we can strive to conquer the challenges of this chronic infection and improve the lives of those affected.

Dr. Camel's Conclusion

This article offers a comprehensive guide to interferon therapy for chronic hepatitis C, emphasizing the importance of personalized treatment and careful monitoring. It’s like a compass in the desert of hepatitis C, helping us navigate the complex landscape of treatment options and find the path to recovery.

Date :
  1. Date Completed 2000-12-07
  2. Date Revised 2019-08-31
Further Info :

Pubmed ID

10921398

DOI: Digital Object Identifier

10.1046/j.1440-1746.2000.02116.x

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.